ASX:HSO

HEALTHSCOPE LIMITED.

James Gerrish

Another very choppy session for the ASX with a lot going on under the surface yet the index finished fairly flat on the day. Banks were weak and the market finds it hard to rally when banks are offered + there was another decent seller of SPI Futures at stages... Show More

Equities
Hugh Dive

The “Dogs of the Dow” is an investment strategy that is based on buying the ten worst performing stocks over the past 12 months from the Dow Jones Industrial Average (DJIA) at the beginning of the year but restricting the stocks selected to those that are still paying a dividend.... Show More

James Gerrish

The local market opened and closed strongly, but everything in the middle was weak and ultimately the index fell for the fourth day running. Equities struggled today as the market grapples with the US Fed progress and the possibility of a US Government shut down. The hail storms that battered... Show More

Expert Insights
Livewire Exclusive

30 years ago, private equity was uncrowded, and less competition meant better deals. Intense competition today means higher valuations, leading to a lower margin of safety. Adrian Warner, Managing Director and CIO of Avenir Capital argues here that public equity markets now offer better pricing opportunities. Adrian has pedigree in private... Show More

Andrew Mitchell

Not unlike the regenerative quality of an Australian summer bushfire, equity market corrections are a necessary evil of healthy and well-functioning markets. More often than not, they allow share markets to recalibrate and consolidate over the shorter-term, whilst also acting as an agent to transfer capital from weaker, short-term hands... Show More

Phil Strano

While reporting season confirmed the continued strength of Australian corporates, private hospital operators were a stark exception, with fundamentals deteriorating due to two notable trends. We discuss these here, and look at Healthscope and Ramsay from a credit perspective. Show More

Luke Cummings

A recent market report from Pitcher Partners found that M & A activity in 2017 increased 55% compared with the prior year, with numerous industry players such as Morgan Stanley, KPMG, and more all suggesting that M & A activity is showing no signs of slowing down just shy of... Show More

Luke Cummings

A recent article from Tony Boyd in the Australian Financial Review shone a light on just how active the domestic Australian market has been for M & A activity in 2018. Our last Livewire submission seven months ago touched on a few key things to look out for when trading... Show More

James Gerrish

Last week was a fascinating one in equity land with MM again becoming bullish the local ASX200 targeting the 6200-6250 area, now only around 3% higher. It was refreshing to see local stocks, even in the face of the Hayne royal commission, sit in the winners cycle of global indices... Show More

James Gerrish

After yesterday’s day off the market was choppy through the morning before selling kicked in - particularly in the banks today. Westpac in particular was sold off hard as UBS heavily reduced their target price and outlook for the bank – more on this later. Healthcare got a boost with... Show More

Roger Montgomery

Recent experience excepted, corrections are typically more frequent and regular than many would prefer, so investing should not occur without acceptance of this. That said, it’s important to prepare, first by making the right investments, and secondly by adopting the right temperament. Show More

Livewire Exclusive

Catherine Allfrey from Wavestone Capital and Chad Slater from Morphic Asset Management highlight the best and worst from reporting season, including one company that Morphic has been openly short on, but has revised its view post-reporting season, saying: “My god, it was a good result.” Show More

Morgans Financial Limited

FY17 underlying results were below expectations, weighed down by continued soft conditions, cost pressures and volatile case mix in the core Hospital division. 
Increased competition and ramping VIC greenfields further pressured Hospital earnings, pushing it below expectations and guidance, and offsetting strong above market gains from brownfields, which remain on... Show More

Livewire Equities

When it re-listed in July 2014 Healthscope was the largest IPO to hit the ASX in four years. Having spent time held by private equity, the $3.6 billion float was priced on a 22x PE. It's been a bumpy ride, but opinions on the outlook are divided ahead of today's... Show More